Sangamo BioSciences | SGMO - 資産

株価
0.25
毎日の変更
-0.01 -4.09%
毎月
-38.64%
毎年
-65.04%
Q2 予測
0.24




資産 変化する 日付
Alaunos Therapeutics USD 3.72M 1.01M 2025-09
Alnylam Pharmaceuticals USD 4.97B 114.67M 2025-12
Alterity Therapeutics Limited AUD 37.98M 15.78M 2025-12
Amgen USD 90.59B 445M 2025-12
Bayer EUR 104.54B 331M 2025-12
BioCryst Pharmaceuticals USD 514.16M 67.73M 2025-12
Biogen USD 29.44B 232M 2025-12
BioMarin Pharmaceutical USD 7.59B 20.85M 2025-12
Cipla INR 401.64B 27.77B 2025-09
Clal Biotechnology ILS 158.39M 24.3M 2023-12
Compugen USD 156.57M 58.73M 2025-12
CSL USD 37.9B 1.5B 2025-12
Gilead Sciences USD 59.02B 490M 2025-12
GlaxoSmithKline GBP 61.12B 221M 2025-12
Grifols EUR 23.15B 142.7M 2025-12
Ionis Pharmaceuticals USD 3.52B 490.91M 2025-12
J&J USD 199.21B 6.39B 2025-12
Karyopharm Therapeutics USD 108.42M 12.18M 2025-12
Merck USD 129.55B 12.02B 2025-09
Novartis USD 110.95B 3.66B 2025-12
Omeros USD 200.57M 34.59M 2025-06
Pfizer USD 208.73B 2.64B 2025-09
Roche Holding CHF 100.7B 5.94B 2025-12
Sangamo BioSciences USD 97.56M 11.39M 2025-06
Sanofi EUR 126.81B 2.99B 2025-12
Sarepta Therapeutics USD 3.35B 143.73M 2025-12
Tectonic Therapeutic USD 261.04M 15.96M 2025-12
Ultragenyx Pharmaceutical USD 1.53B 341.56M 2025-12
Vertex Pharmaceuticals USD 25.64B 780.7M 2025-12